ANDRES
MOYA SIMARRO
CATEDRÁTICO/A DE UNIVERSIDAD
Harvard Medical School
Boston, Estados UnidosPublicaciones en colaboración con investigadores/as de Harvard Medical School (2)
2016
-
Active and secretory IgAcoated bacterial fractions elucidate dysbiosis in Clostridium difficile infection
mSphere, Vol. 1, Núm. 3
-
The monoclonal antitoxin antibodies (actoxumab-bezlotoxumab) treatment facilitates normalization of the gut microbiota of mice with Clostridium difficile infection
Frontiers in Cellular and Infection Microbiology, Vol. 6, Núm. OCT